Unclaimed Scholar Profile
Are you Anna Schuh? This profile has been curated from verified academic registries. Claim your profile to edit affiliations, manage works, and access your dashboard.
Verified ScholarVerified at Muhimbili University of Health and Allied SciencesASIDASID-3521-3585-2305 orcid.org/0000-0002-3938-8490
Anna Schuh
Muhimbili University of Health and Allied Sciences
Faculty researcher at Muhimbili University of Health and Allied Sciences (TZ), specializing in Social Sciences & Humanities. [Discipline: Social Sciences & Humanities] [Scholar Type: Journal Research Scientist] [Career Tier: Distinguished Scholar] [Region: East Africa]
#Chronic Lymphocytic Leukemia Research#Lymphoma Diagnosis and Treatment#Acute Lymphoblastic Leukemia research#Cancer Genomics and Diagnostics
Scholarly Profiles: Google Scholar
Citation Indices
Standard Scientometrics| All | Since 2021 | |
|---|---|---|
| Citations | 23,448 | 11,255 |
| h-index | 60 | 45 |
| i10-index | 158 | 111 |
Annual Citation Growth
Verified Citations / Year0
20201.1k
2021+40%1.6k
2022+29%2.0k
2023+33%2.7k
2024-8%2.5k
2025-45%1.4k
2026Scholarship Distribution & Proportions383 Articles • 0 Books & Monographs • 0 Applied Assignments
Continental Provenance:25% African Regional Citations (5,862) • 75% Global Research Impact (17,586)
383 Indexed WorksAuthentic Data
Co-Authors & Academic Collaborators
No verified co-authors registered on AfriJournal Index yet.
Browse African Scholars →Scientific Bibliography Ingestion Notice
AfriJournal Index synchronizes authentic African citations and scholarship from Crossref, OpenAlex, and verified institutional repositories. Due to external indexing latency, some historical works may not yet be ingested in this snapshot. If you are this scholar, claim this profile to link your ORCID and verify your complete bibliography.
Articles & Books (383)
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
Published in Leukemia•2022
DOI: 10.1038/s41375-022-01613-1 Verified Peer-Reviewed
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
Published in Leukemia•2022
DOI: 10.1038/s41375-022-01620-2 Verified Peer-Reviewed
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
Published in New England Journal of Medicine•2014
DOI: 10.1056/nejmoa1400376 Verified Peer-Reviewed
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
Published in New England Journal of Medicine•2015
DOI: 10.1056/nejmoa1509388 Verified Peer-Reviewed
Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia
Published in New England Journal of Medicine•2015
DOI: 10.1056/nejmoa1509981 Verified Peer-Reviewed
Showing 1 – 5 of 383 publications
1 / 77